'
1. Report Overview
1.1 Introduction to Meningococcal Vaccines Market
1.2 Meningococcal Vaccines Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Primary Research
1.7.2 Secondary Research
1.7.3 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About
2 Executive Summary
3 Market Dynamics
3.1 Drivers
3.1.1 Increasing prevalence of meningitis
3.1.2 Increasing initiatives by government and regulatory authorities
3.1.3 Presence of Non-profit Organizations Providing funds for research projects
3.1.4 Vaccine trials and are expected to commercialized during the forecast period
3.2 Restraints
3.2.1 Low Production rate and high cost
3.2.2 High Costs of Drug Development Limits the Entry of New Players
3.2.3 Long Vaccine Manufacturing Timelines to Impede the Growth of the Vaccines Market
3.3 Opportunities
3.3.1 Increasing Inclusion in NIPs Unlocking New Windows of Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Supplier: Moderate
3.4.2 Bargaining Power of Buyer: Moderate
3.4.3 Competitive Rivalry: High
3.4.4 Threat of New Entrants: low
3.4.5 Threat of Substitutes: Low
3.5 PEST Analysis
3.5.1 Political Factors Impacting Meningococcal Vaccines Market
3.5.2 Economic Factors Impacting Meningococcal Vaccines Market
3.5.3 Social Factors Impacting Meningococcal Vaccines Market
3.5.4 Technological Factors Impacting Meningococcal Vaccines Market
4 Meningococcal Vaccines Market by Vaccine Type Forecast, 2021-2031
4.1 Conjugate Segment Market Forecast, 2021-2031
4.1.1 Increasing investment of Government and Private sectors in the development of conjugate Vaccines
4.1.2 Global Meningococcal Vaccines Market for Conjugate Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
4.2 Polysaccharide Segment Market Forecast, 2021-2031
4.2.1 Polysaccharide Vaccines is expected to hold Largest Market Share over the forecast period
4.2.2 Global Meningococcal Vaccines Market for Polysaccharide Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
4.3 Other Segment Market Forecast, 2021-2031
4.3.1 The outer membrane vesicles containing membrane proteins (OMVs) and lipopolysaccharide (LPS)
4.3.2 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5 Meningococcal Vaccines Market by End User Forecast, 2021-2031
5.1 Pediatric Segment Market Forecast, 2021-2031
5.1.1 Largest Revenue Grossing Segment
5.1.2 Global Meningococcal Vaccines Market for Pediatric Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5.2 Adult Segment Market Forecast, 2021-2031
5.2.1 Adult population, between age group 18 to 58, is prone to developing respiratory diseases
5.2.2 Global Meningococcal Vaccines Market for Adult Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5.3 Travellers Segment Market Forecast, 2021-2031
5.3.1 Travellers visiting areas with high endemic needs vaccination with a limit of 5 years prior to next travel
5.3.2 Global Meningococcal Vaccines Market for Travellers Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
6 Meningococcal Vaccines Market by Vaccine Brand Forecast, 2021-2031
6.1 Bexsero Segment Market Forecast, 2021-2031
6.1.1 Bexsero- multicomponent meningococcal group B recombinant adsorbed vaccine
6.1.2 Global Meningococcal Vaccines Market for Bexsero Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
6.2 Menactra Segment Market Forecast, 2021-2031
6.2.1 Menactra vaccine protects against infection by one of the most common types of meningococcal bacteria
6.2.2 Global Meningococcal Vaccines Market for Menactra Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
6.3 Menveo Segment Market Forecast, 2021-2031
6.3.1 Menveo Vaccine is advised children, adolescents, and adults to prevent invasive meningococcal disease
6.3.2 Global Meningococcal Vaccines Market for Menveo Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
6.4 Others Segment Market Forecast, 2021-2031
6.4.1 Vaccine MenAC projected for infants by reducing cost and without the essential for further vaccination visits or injections
6.4.2 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
7 Global Meningococcal Vaccines Market Regional Forecast, 2021-2031
7.1 Global Meningococcal Vaccines Market by Region Forecast 2021-2031
7.2 Global Meningococcal Vaccines Market Forecast by Region: Recovery Scenarios (V, U, W, L)
8 North America Meningococcal Vaccines Market, 2021-2031
8.1 Largest Market Share acquired by North America in Global Meningococcal Vaccines Market
8.2 North America Meningococcal Vaccines Market by Country, Forecast 2021-2031
8.3 North America Meningococcal Vaccines Market Forecast by Vaccine Type
8.3.1 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031: Recovery Scenarios (V, U, W, L)
8.4 North America Meningococcal Vaccines Market Forecast by End User
8.4.1 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
8.5 North America Meningococcal Vaccines Market Forecast by Vaccine Brand
8.5.1 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031: Recovery Scenarios (V, U, W, L)
8.6 U.S. Meningococcal Vaccines Market Forecast, 2021-2031
8.6.1 Growing awareness and support from various organizations
8.6.2 Presence of Highly Developed Healthcare Infrastructure
8.6.3 U.S. Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
8.7 Canada Meningococcal Vaccines Market Forecast, 2021-2031
8.7.1 Benefits of manufacturing and R&D Operations in Canada
8.7.2 Canada Government and GSK Supporting for Meningitis Vaccination
8.7.3 Canada Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9 Europe Meningococcal Vaccines Market, 2021-2031
9.1 Favourable Government Support
9.2 Europe Meningococcal Vaccines Market by Country, Forecast 2021-2031
9.3 Europe Meningococcal Vaccines Market Forecast by Vaccine Type
9.3.1 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031: Recovery Scenarios (V, U, W, L)
9.4 Europe Meningococcal Vaccines Market Forecast by End User
9.4.1 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
9.5 Europe Meningococcal Vaccines Market Forecast by Vaccine Brand
9.6 Germany Meningococcal Vaccines Market Forecast, 2021-2031
9.6.1 Strong Research and Development with new vaccines in pipeline
9.6.2 Meningococcal B vaccination has not yet been introduced in the vaccination schedule in Germany
9.6.3 Germany Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.7 U.K. Meningococcal Vaccines Market Forecast, 2021-2031
9.7.1 Growing ageing population creating challenges
9.7.2 Growing awareness campaigns among population
9.7.3 U.K. Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.8 France Meningococcal Vaccines Market Forecast, 2021-2031
9.8.1 Affordable Healthcare Services with Workforce Flexibility
9.8.2 France government vaccination programme and low uptake of Meningococcal C Vaccine in France
9.8.3 France Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.9 Italy Meningococcal Vaccines Market Forecast, 2021
9.9.1 Italy Vaccination programme
9.9.2 Italy –Growing geriatric population coupled with increase in no of cases of Invasive Meningococcal Disease (IMD)
9.9.3 Italy Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.10 Spain Meningococcal Vaccines Market Forecast, 2021-2031
9.10.1 Experience in A Limited Release of the Vaccine for Private Market Use in Spain
9.10.2 Rise in the incidence rate of IMD in Adults
9.10.3 Spain Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.11 Russia Meningococcal Vaccines Market Forecast, 2021-2031
9.11.1 Promising Russian Pharmaceutical Industry
9.11.2 Promising partnership by Sanofi and Nanolek against Meningococcal infection
9.11.3 Russia Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.12 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031
9.12.1 Growing prevalence of bacterial infections and strategic initiatives by major market players
9.12.2 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10 Asia Pacific Meningococcal Vaccines Market, 2021-2031
10.1 Increased funding for vaccines and immunization in developing countries
10.2 Invasive respiratory tract infections, and smoking and overcrowded living conditions and specific adolescent social behaviour are risk factors in developing countries
10.3 Asia Pacific Meningococcal Vaccines Market by Country, Forecast 2021-2031
10.4 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type
10.4.1 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031: Recovery Scenarios (V, U, W, L)
10.5 Asia Pacific Meningococcal Vaccines Market Forecast by End User
10.5.1 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
10.6 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Brand
10.7 Japan Meningococcal Vaccines Market Forecast, 2021-2031
10.7.1 Japan Accounted for the Largest Market Share in the Asia Pacific region
10.7.2 Meningitis and the Olympics: Japan 2020
10.7.3 Japan Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.8 China Meningococcal Vaccines Market Forecast, 2021-2031
10.8.1 Growing Government initiatives to boost the market demand
10.8.2 Increasing Healthcare Spending Propels the Market Growth
10.8.3 China Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.9 India Meningococcal Vaccines Market Forecast, 2021-2031
10.9.1 Meningococcal disease burden data remain unreliable
10.9.2 Developing Healthcare Infrastructure
10.9.3 India Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.10 Australia Meningococcal Vaccines Market Forecast, 2021-2031
10.10.1 Australia is one of the major country to include Meningococcal ACWY vaccine through NIP
10.10.2 Government initiatives and spread of meningococcal disease in Australia
10.10.3 Australia Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.11 South Korea Meningococcal Vaccines Market Forecast, 2021-2031
10.11.1 Spreading HIV in South Korea Region
10.11.2 IMD in South Korea Region
10.11.3 South Korea Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.12 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031
10.12.1 Burden of meningococcal disease is high among children throughout the Asia Pacific region
10.12.2 Risk and burden of IMD across the Asia Pacific region is relatively low
10.12.3 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
11 Latin America Meningococcal Vaccines Market, 2021-2031
11.1 Unavailability of data has contributed to uncertain policy decisions
11.2 Need to improve surveillance in Latin America region
11.3 Latin America Meningococcal Vaccines Market by Country, Forecast 2021-2031
11.4 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type
11.4.1 Latin America Meningococcal Vaccines Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
11.5 Latin America Meningococcal Vaccines Market Forecast by End User
11.5.1 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
11.6 Latin America Meningococcal Vaccines Market Forecast by Vaccine Brand
11.7 Brazil Meningococcal Vaccines Market Forecast, 2021-2031
11.7.1 Country with highest documented levels of Invasive Meningococcal Disease
11.7.2 Prevalence of Meningococcal disease due to other serogroups which continues to be major concern
11.7.3 Brazil Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
11.8 Mexico Meningococcal Vaccines Market Forecast, 2021-2031
11.8.1 Mexico- Attractive market to capitalize in the Pharmaceutical Industry
11.8.2 Mexico- Meningococcal meningitis is reported as a rare condition
11.8.3 Recovery Scenarios (V, U, W, L): Mexico Meningococcal Vaccines Market Forecast, 2021-2031
11.9 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031
11.9.1 Evolving Healthcare Infrastructure
11.9.2 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
12 Middle East and Asia Meningococcal Vaccines Market, 2021-2031
12.1 Middle East and Africa Meningococcal Vaccines Market by Country, Forecast 2021-2031
12.2 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type
12.2.1 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031: Recovery Scenarios (V, U, W, L)
12.3 Middle East and Africa Meningococcal Vaccines Market Forecast by End User
12.3.1 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
12.4 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Brand
12.5 South Africa Meningococcal Vaccines Market Forecast, 2021-2031
12.5.1 African meningitis belt – Region with highest burden of disease
12.5.2 Growing GDP and Substantial progress in the management of infectious diseases
12.5.3 South Africa Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
12.6 GCC Meningococcal Vaccines Market Forecast, 2021-2031
12.6.1 Government funding and immunization is not major constraint in this region
12.6.2 UNICEF and partners could promote active sharing of information topics among MENA Countries
12.6.3 GCC Meningococcal Vaccines Market Forecast 2021-2031: Recovery Scenarios (V, U, W, L):
12.7 Rest of Middle East and Asia Meningococcal Vaccines Market Forecast, 2021-2031
12.7.1 Developing Pharmaceutical Industry along with government support
12.7.2 Under developed countries in the region supported by GAVI along with government support
12.7.3 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
13 Company Profiles
13.1 Company Share Analysis
13.2 Meningococcal vaccine market Recent Developments 2018-2020
13.1 Sanofi
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Analysis
13.1.3.1 Net Revenue, 2016-2020
13.1.3.2 Regional Revenue Shares, 2020
13.1.3.3 Product Revenue Shares, 2020
13.1.4 Product Benchmarking
13.1.5 Recent Developments, 2017-2021
13.2 Merck & Co., Inc.
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Analysis
13.2.3.1 Net Revenue, 2015-2019 or 2016-2021
13.2.3.2 Regional Revenue Shares, 2020
13.2.3.3 Product Revenue Shares, 2020
13.2.4 Product Benchmarking
13.3 GlaxoSmithKline plc.
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2016-2020
13.3.3.2 Regional Revenue Shares, 2020
13.3.3.3 Product Revenue Shares, 2020
13.3.4 Product Benchmarking
13.3.5 Recent Developments, 2017-2021
13.4 Pfizer Inc.
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2016-2020
13.4.3.2 Regional Revenue Shares, 2020
13.4.3.3 Product Revenue Shares, 2020
13.4.4 Product Benchmarking
13.4.5 Recent Developments, 2017-2021
13.5 Serum Institute of India Pvt. Ltd.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Product Benchmarking
13.6 Zhi Fei Biological
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Product Benchmarking
13.7 Hualan Biological Engineering Inc
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Product Benchmarking
13.7.4 Recent Developments, 2017-2021
13.8 Incepta Pharmaceuticals Ltd.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Product Benchmarking
13.9 Walvax Biotechnology Co., Ltd.
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Product Benchmarking
13.10 BIO-MED
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Product Benchmarking
13.11 JN International Medical Corporation
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Product Benchmarking
14 Conclusion and Recommendations
14.1 Concluding Remarks from
14.2 Recommendations for Market Players
14.3 Global Meningococcal Vaccines Market Share Forecast by Region
List of Tables
Table 1 Global Meningococcal Vaccines Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
Table 2 Global Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 3 Global Meningococcal Vaccines Market for Conjugate Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 4 Global Meningococcal Vaccines Market for Conjugate Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 5 Global Meningococcal Vaccines Market for Conjugate Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 6 Global Meningococcal Vaccines Market for Conjugate Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 7 Global Meningococcal Vaccines Market for Conjugate Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 8 Global Meningococcal Vaccines Market for Polysaccharide Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 9 Global Meningococcal Vaccines Market for Polysaccharide Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 10 Global Meningococcal Vaccines Market for Polysaccharide Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 11 Global Meningococcal Vaccines Market for Polysaccharide Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 12 Global Meningococcal Vaccines Market for Polysaccharide Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 13 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 14 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 15 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 16 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 17 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 18 Global Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 19 Global Meningococcal Vaccines Market for Pediatric Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 20 Global Meningococcal Vaccines Market for Pediatric Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 21 Global Meningococcal Vaccines Market for Pediatric Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 22 Global Meningococcal Vaccines Market for Pediatric Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 23 Global Meningococcal Vaccines Market for Pediatric Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 24 Global Meningococcal Vaccines Market for Adult Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 25 Global Meningococcal Vaccines Market for Adult Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 26 Global Meningococcal Vaccines Market for Adult Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 27 Global Meningococcal Vaccines Market for Adult Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 28 Global Meningococcal Vaccines Market for Adult Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 29 Global Meningococcal Vaccines Market for Travellers Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 30 Global Meningococcal Vaccines Market for Travellers Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 31 Global Meningococcal Vaccines Market for Travellers Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 32 Global Meningococcal Vaccines Market for Travellers Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 33 Global Meningococcal Vaccines Market for Travellers Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 34 Global Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 35 Global Meningococcal Vaccines Market for Bexsero Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 36 Global Meningococcal Vaccines Market for Bexsero Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 37 Global Meningococcal Vaccines Market for Bexsero Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 38 Global Meningococcal Vaccines Market for Bexsero Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 39 Global Meningococcal Vaccines Market for Bexsero Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 40 Global Meningococcal Vaccines Market for Menactra Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 41 Global Meningococcal Vaccines Market for Menactra Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 42 Global Meningococcal Vaccines Market for Manactra Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 43 Global Meningococcal Vaccines Market for Menactra Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 44 Global Meningococcal Vaccines Market for Menactra Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 45 Global Meningococcal Vaccines Market for Menveo Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 46 Global Meningococcal Vaccines Market for Menveo Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 47 Global Meningococcal Vaccines Market for Menveo Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 48 Global Meningococcal Vaccines Market for Menveo Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 49 Global Meningococcal Vaccines Market for Menveo Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 50 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 51 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 52 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 53 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 54 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 55 Global Meningococcal Vaccines Market Forecast by Region, 2021-2031 (US$ mn, AGR%, 6CAGR %)
Table 56 Global Meningococcal Vaccines Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 57 Global Meningococcal Vaccines Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 58 Global Meningococcal Vaccines Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 59 Global Meningococcal Vaccines Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 60 North America Meningococcal Vaccines Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 61 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 62 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 63 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 64 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 65 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 66 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 67 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 68 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 69 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 70 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 71 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 72 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 73 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 74 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 75 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 76 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 77 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 78 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 79 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 80 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 81 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 82 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 83 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 84 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 85 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 86 Europe Meningococcal Vaccines Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 87 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 88 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 89 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 90 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 91 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 92 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 93 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 94 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 95 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 96 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 97 Europe Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 98 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 99 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 100 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 101 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 102 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 103 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 104 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 105 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 106 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 107 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 108 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 109 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 110 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 111 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 112 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 113 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 114 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 115 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 116 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 117 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 118 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 119 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 120 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 121 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 122 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 123 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 124 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 125 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 126 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 127 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 128 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 129 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 130 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 131 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 132 Rest of Euro
